NABP Exam FPGEE Topic 8 Question 99 Discussion

Actual exam question for NABP's FPGEE exam

Question #: 99
Topic #: 8

[All FPGEE Questions]

Indication of leukotrienes modifiers in the treatment of asthma includes which of the following?

I- Acute treatment

II- Prophylaxis

III- Chronic treatment

AI only

BIII only

CI and II only

DII and III only

EAll are correct

Show Suggested Answer

Suggested Answer: D

by Dominga at Jan 14, 2025, 08:46 PM

Limited Time Offer

25%

Off

Get Premium FPGEE Questions as Interactive Web-Based Practice Test or PDF

Contribute your Thoughts:

Submit Cancel

Anisha

1 months ago

D, definitely. I just hope the exam doesn't ask us to name all the leukotrienes - that's a whole other can of worms!

upvoted 0 times

...

Valentin

2 months ago

Hmm, I was thinking it's E, but D makes more sense. Leukotrienes are the new kids on the block in the asthma treatment game.

upvoted 0 times

Leeann

1 months ago

I agree, D is the right choice. They are not typically used for acute treatment.

upvoted 0 times

...

Aliza

1 months ago

I think D is the correct answer. Leukotrienes modifiers are used for prophylaxis and chronic treatment.

upvoted 0 times

...

Elden

1 months ago

Yeah, I agree. They are not typically used for acute treatment, so I would go with D as well.

upvoted 0 times

...

Kiera

1 months ago

I think D is the correct answer. Leukotrienes modifiers are used for both prophylaxis and chronic treatment.

upvoted 0 times

...

Charlie

2 months ago

I think it might also include prophylaxis, so maybe it's D) II and III only.

upvoted 0 times

...

Casie

2 months ago

I agree, option D is the right answer. Leukotrienes play a key role in the long-term management of asthma symptoms.

upvoted 0 times

...

Bong

2 months ago

The correct answer is D. Leukotrienes modifiers are used for prophylaxis and chronic treatment of asthma, not acute treatment.

upvoted 0 times

Remedios

26 days ago

Yes, they are mainly used for prophylaxis and chronic treatment of asthma.

upvoted 0 times

...

Mica

1 months ago

That makes sense, leukotrienes modifiers are not typically used for acute treatment.

upvoted 0 times

...

Virgilio

2 months ago

I think the correct answer is D) II and III only.

upvoted 0 times

...

Terina

2 months ago

I agree with Markus, I believe it is III only.

upvoted 0 times

...

Markus

2 months ago

I think the indication of leukotrienes modifiers includes chronic treatment.

upvoted 0 times

...